FDA Actions in Brief as reported September 1, 2001
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Big Beautiful Bill Reduces Drugs Eligible for Price Negotiations
Read More
ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain
Updated: FDA Approves Leqembi Autoinjector for Maintenance Dosing in Alzheimer’s
Teva Launches First Generic GLP-1 Drug for Obesity
Novo Nordisk Teams with Form Health, 9amHealth for Obesity Care
Lilly’s Oral GLP-1 Meets Endpoints in Phase 3 Trial